Quote of the day by George Michael explores the meaning of change through the words “Change is a stranger you have yet to know.” The articl...

New Zealand is easing health insurance rules for the Peak Seasonal Visa starting April 19, 2026. This change aims to simplify compliance fo...

Anthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...

A mother in Punjab's Kapurthala tragically lost all her sons to chitta, also known as drugs. The critically ill patient died at Amritsar Me...

India's decision to reject a waiver for local clinical trials of a new HIV drug, lenacapavir, is causing concern. Public health experts war...

Lupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...

Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, ha...

Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agr...

Lenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...

A new "vaccine-like" HIV drug that currently costs over $40,000 per person a year could be made for as little as $40, researchers estimated...

Additional Chief Secretary (Medical and Health) Rohit Kumar Singh said the patients' condition improved after they were administered the an...

Cipla, the sole producer of lopinavir/ritonavir, a combination HIV drug prescribed for paediatric patients, has stopped manufacturing it ov...

Scientists have developed a new delivery system for a combination of two HIV drugs that may serve as an effective treatment for the deadly ...

An independent mechanism that protects the patent rights of Big Pharma while allowing generic firms to sell cheap, copycat HIV drugs to poo...

India has rejected American drugmaker Bristol-Myers Squibb's (BMS) patent application for one of its HIV drugs, allowing local drugmakers t...

Besides I-MAK, a few local HIV drug makers such as Cipla and US-based Mylan-owned Matrix Laboratories had also opposed Abbott's attempt to ...

In a bid to make anti-cancer and HIV drugs more accessible, the government is planning to ask public sector drug makers to manufacture anti...